Brimonidine 0.2% to prevent post laser IOP elevation.
Kasahara
Niro
N
D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000068438:Brimonidine Tartrate; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D007498:Iris / Q000601:surgery; D053685:Laser Therapy / Q000009:adverse effects*; D009798:Ocular Hypertension / Q000209:etiology / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D011810:Quinoxalines / Q000008:administration & dosage*; D014130:Trabeculectomy
D000959:Antihypertensive Agents; D011810:Quinoxalines; D000068438:Brimonidine Tartrate